ReviewEuropean endocrinology2019
Advances in Type 1 Diabetes Technology Over the Last Decade.
Review in European endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Advanced Hybrid Closed Loop in Adult Population With Type 1 Diabetes: A Substudy From the ADAPT Randomized Controlled Trial in Users of Real-Time Continuous Glucose Monitoring.Journal of diabetes science and technology · 2024Trial
- Caregiver experiences of an integrative patient-centered digital health application for pediatric type 1 diabetes care: Findings from a pilot clinical trial.PLOS digital health · 2025Article
- A Qualitative Analysis of Provider-Level Barriers to Prescribing Diabetes Technology.Journal of diabetes research · 2025Article
- Augmenting clinicians' analytical workflow through task-based integration of data visualizations and algorithmic insights: a user-centered design study.Journal of the American Medical Informatics Association : JAMIA · 2024Article
- The Interplay between Dietary Habits and Glycemic Control in Type 1 Diabetes: A Comprehensive Prospective FGM Study.Life (Basel, Switzerland) · 2024Article
- Parent, child, and adolescent lived experience using the insulin-only iLet Bionic Pancreas.Journal of pediatric psychology · 2024Article
- A review of CONCEPTT study findings including subanalyses in pregnant women using continuous glucose monitoring with type 1 diabetes and their offspring.Endocrine connections · 2024Review
- Development of a Multivariable Risk Prediction Tool to Predict Adverse Outcomes among Children with Type 1 Diabetes: A Pilot Study.Pediatric diabetes · 2024Article
- Mortality assessment for pancreas transplants in the United States over the decade 2008-2018.World journal of transplantation · 2023Article
- Demographic and Glycemic Factors Linked With Diabetes Distress in Teens With Type 1 Diabetes.Journal of pediatric psychology · 2022Article
- Development of Peer Relationships From Adolescence into Emerging Adulthood: Comparing Males and Females With and Without Type 1 Diabetes.Journal of pediatric psychology · 2022Article
- Glycemic control of adult patients with type 1 diabetes mellitus in Arabian Gulf Countries; PREDICT.BMC endocrine disorders · 2022Observational
- Leveraging advances in diabetes technologies in primary care: a narrative review.Annals of medicine · 2021Review
- Insulin and takotsubo syndrome: plausible pathophysiologic, diagnostic, prognostic, and therapeutic roles.Acta diabetologica · 2021Review
- Diabetes-specific friend support in emerging adults with type 1 diabetes: Does satisfaction with support matter?Journal of behavioral medicine · 2021Article
- 'Smart' insulin-delivery technologies and intrinsic glucose-responsive insulin analogues.Diabetologia · 2021Review
- Study of blood glucose and insulin infusion rate in real-time in diabetic rats using an artificial pancreas system.PloS one · 2021Article
- The durability and effectiveness of sensor-augmented insulin pump therapy in pediatric and young adult patients with type 1 diabetes.Annals of pediatric endocrinology & metabolism · 2020Article
- Type 1 Diabetes in Singapore: Self-Care Challenges, Diabetes Technology Awareness, Current Use, and Satisfaction, an Online Survey.Indian journal of endocrinology and metabolismArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The past 10 years have witnessed rapid advances in the technology used to treat patients with type 1 diabetes (T1D). While the disease burden is still high, these advances have contributed to improvements in both glycaemic control and quality of life for many of those affected. New technologies allow for individualisation of care, as patients are able to work with their providers to determine which systems best fit their lifestyle and needs. In addition, thanks to improved glucose monitoring technologies, patients can now simultaneously improve glycaemic control and reduce hypoglycaemia, thereby mitigating risk for acute and chronic complications. Technological advances in T1D care are rapidly moving us toward increasingly automated devices, which offer the promise of reduced disease burden. In this article, we review advances in glucose monitoring, insulin and glucagon delivery, and the applications and algorithms seeking to integrate novel technologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.